Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased
Published inKidney international, vol. 102, no. 6, p. 1409-1419
Publication date2022-12
First online date2022-09-10
Abstract
Keywords
- COVID vaccine
- IgA nephropathy
- SARS-CoV-2 vaccination
- Glomerulonephritis
- Membranous nephropathy
- Minimal change disease
- Adult
- Humans
- Incidence
- Retrospective Studies
- Bayes Theorem
- COVID-19 Vaccines / adverse effects
- SARS-CoV-2
- COVID-19 / epidemiology
- COVID-19 / prevention & control
- Glomerulonephritis / epidemiology
- Glomerulonephritis / etiology
- Vaccination / adverse effects
- RNA, Messenger
Citation (ISO format)
DIEBOLD, Matthias et al. Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased. In: Kidney international, 2022, vol. 102, n° 6, p. 1409–1419. doi: 10.1016/j.kint.2022.08.021
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
- PID : unige:166504
- DOI : 10.1016/j.kint.2022.08.021
- PMID : 36096267
- PMCID : PMC9462927
ISSN of the journal0085-2538